Trifluridine/Tipiracil in the Real-World Management of Metastatic Gastric and Gastroesophageal Junction Cancers in Canada

Background: Gastric cancer mortality remains among the highest of all cancers. Trifluridine/tipiracil (FTD/TPI) represents Canada’s first standard-of-care, third-line, systemic therapy for metastatic gastric/gastroesophageal cancer. We characterized real-world treatment patterns in patients enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Philip Q., Dolley, Aastha, Cheung, Winson Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857321/
https://www.ncbi.nlm.nih.gov/pubmed/36661660
http://dx.doi.org/10.3390/curroncol30010011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857321/
https://www.ncbi.nlm.nih.gov/pubmed/36661660
http://dx.doi.org/10.3390/curroncol30010011

Ejemplares similares